PENSACOLA, Fla., August 19, 2026 — Aurushi, an adaptive apparel brand designing clothing for people who use prosthetics, orthotics, braces, or otherwise navigate mobility challenges, is now available to federal healthcare customers through Lovell Government Services, a Service-Disabled Veteran-Owned Small Business (SDVOSB). Through the partnership, Department of Veterans Affairs (VA) and other federal healthcare organizations have streamlined access to apparel designed around the everyday realities of living with a limb difference or mobility device.

 

Founded by a below-knee amputee, Aurushi was created from firsthand experience with the challenges conventional clothing can present for people adapting to and living with prosthetic devices. Mainstream apparel is rarely designed to accommodate the frequent adjustments, access needs, fit considerations, and daily routines associated with prosthetics and orthotics. Aurushi addresses these challenges by integrating adaptive functionality directly into garments while maintaining a focus on contemporary style.

 

Aurushi apparel incorporates features such as full-length side zippers, discreet openings that provide access for adjustments, and fits designed to accommodate prostheses and orthoses. These details can make dressing and accessing mobility devices more practical while allowing wearers to choose clothing based on personal style rather than solely on what their device will accommodate.

 

With the VA serving Veterans living with amputation, limb loss, and a wide range of mobility-related needs, access to purpose-built adaptive apparel can help address practical challenges that extend beyond the clinical setting. Clothing is part of everyday life, and for individuals who use prosthetics, orthotics, and braces, conventional garments can create obstacles to dressing, device access, adjustment, comfort, and mobility.

 

“Aurushi was born from my own experience of becoming an amputee and realizing how little of the clothing around me was designed for the realities of living with a prosthesis,” said Gabriel Cardier, Co-Founder of Aurushi. “We believe adaptive clothing should be functional without asking people to compromise their sense of style or identity. Working with Lovell Government Services gives us an opportunity to bring that philosophy to more Veterans and others who deserve clothing designed with their everyday lives in mind.”

 

Aurushi’s design philosophy is rooted in the Japanese concept of kintsugi, the practice of repairing broken pottery with gold rather than concealing where it was broken. Drawing inspiration from that philosophy, Aurushi approaches the experiences and visible marks of what its customers have been through as sources of strength rather than something to hide. Its tagline, “Crafted for your comeback,” reflects the brand’s focus on creating apparel that supports people as they adapt, recover, and move forward.

 

As federal healthcare continues to address the broader needs of Veterans and other beneficiaries living with limb differences and mobility challenges, adaptive products can play an important role in supporting independence and everyday quality of life. Through Lovell Government Services, Aurushi is expanding its reach into the federal marketplace and making purpose-built adaptive apparel more accessible to the communities it was designed to serve.

 

“Veterans living with limb loss and mobility challenges deserve access to products that recognize their needs both inside and outside the clinical environment,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “Aurushi brings firsthand understanding to a category that has historically been overlooked. We’re proud to work with a company that has turned lived experience into thoughtful, functional products and to help make those products more accessible to Veterans through the federal marketplace.”

For more information about Aurushi and its availability through Lovell Government Services, visit www.lovellgov.com.

About Aurushi

Aurushi is an adaptive apparel brand designing clothing for people who use prosthetics, orthotics, or braces, or who otherwise navigate mobility challenges. The brand was founded by a below-knee amputee whose own experience adapting to a prosthesis, and to the limits of what mainstream clothing could accommodate, shaped Aurushi’s approach to design.

Rooted in the Japanese concept of kintsugi, the practice of repairing broken pottery with gold rather than concealing the break, Aurushi treats the marks of what its customers have been through as a source of strength rather than something to hide. The result is apparel built around the daily, practical realities of living with a limb difference or mobility device, engineered for function without compromising on style. Aurushi’s tagline, “Crafted for your comeback,” reflects that same philosophy.

About Lovell Government Services

Lovell Government Services is a trusted Service-Disabled Veteran-Owned Small Business (SDVOSB) that has been helping companies succeed in the federal market since 2013. As a four-time Inc. 5000 honoree, Lovell partners with medical device, pharmaceutical, and healthcare technology companies to serve Veterans and military communities through federal contracting while helping suppliers expand their government sales and secure contract opportunities.

Learn more at www.lovellgov.com.

Jeff McKay
Lovell Government Services
+1 949-922-8523
email us here
Visit us on social media:
LinkedIn

PENSACOLA, Fla., August 12, 2026 — SKINEEZ®, a patented hydrating compression and skincarewear platform, today announced expanded federal availability through Lovell Government Services, a Service-Disabled Veteran-Owned Small Business (SDVOSB) specializing in government healthcare procurement. The partnership gives federal clinicians and purchasing teams a streamlined path to a broad portfolio of compression socks, stockings, sleeves, gloves, and specialty garments engineered to unite therapeutic compression with continuous skin-conditioning comfort.

The portfolio is available for procurement across the Department of Defense and its military branches—the Army, Navy, Air Force, Marine Corps, Coast Guard, and Space Force—as well as the Department of Veterans Affairs, Indian Health Service, and other eligible federal healthcare organizations. Availability does not imply endorsement by, or adoption across, every named agency or branch.

“This is bigger than a product launch. It is a new standard of care and comfort for the people who serve.”

Traditional compression can be difficult to wear consistently when skin is dry, fragile, or uncomfortable. SKINEEZ addresses that challenge by combining graduated compression with patented microencapsulation technology that releases skin-conditioning ingredients during wear. The result is a differentiated platform built around two goals that matter in federal care: therapeutic performance and a better wearing experience that may support adherence.

“From an active-duty service member preparing for the next mission to a Veteran managing a chronic condition, comfort can determine whether compression therapy stays in the drawer or becomes part of daily life,” said Michelle Moran, Founder and CEO of SKINEEZ. “Together with Lovell, we are opening a clearer path for federal clinicians and procurement teams to access American-made innovation designed to care for the people who protect and serve our country.”

A Platform Built for the Full Continuum of Service

SKINEEZ is positioned to support a wide range of clinician-directed compression and recovery needs, including lymphedema and edema management, chronic venous conditions, post-operative recovery, prolonged standing, travel-related swelling, skin comfort, and physical recovery. Product selection, compression level, and intended use should be matched to each product’s labeling and the patient’s clinical needs.

The portfolio includes more than 145 product configurations spanning compression socks and stockings, arm and leg sleeves, gloves, and specialty garments. This breadth gives federal healthcare teams options for different anatomical needs, compression levels, care settings, and patient populations while consolidating access through Lovell’s established federal contracting channels.

American Innovation, Federal Reach

SKINEEZ is proudly woman-owned and Made in the USA. Through Lovell, that domestic innovation is paired with federal market expertise, contract access, and procurement support—helping reduce friction between an identified clinical need and the product reaching the provider or patient.

“Lovell exists to help federal healthcare professionals find and procure meaningful innovations that can improve care for military members, Veterans, and federal beneficiaries,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “SKINEEZ brings a distinctive combination of compression, skin-conditioning technology, patient comfort, and American manufacturing. We are proud to help make the portfolio accessible through our federal contracting channels.”

One Partnership. A Nationwide Opportunity to Serve.

The SKINEEZ-Lovell partnership creates a platform for education, evaluation, and procurement across military treatment facilities, VA medical centers, federal clinics, occupational health programs, and other authorized government care settings. Federal buyers and healthcare professionals can contact Lovell Government Services to identify applicable products, contracting pathways, and ordering information.

About SKINEEZ®

SKINEEZ® develops patented hydrating compression and skincarewear that combines graduated compression with skin-conditioning technology designed to improve comfort during wear. Proudly woman-owned and Made in the USA, SKINEEZ products are offered through healthcare, pharmacy, retail, and federal procurement channels. Product regulatory status and claims vary by SKU; consult the applicable product labeling for intended use and clearance information.

About Lovell Government Services

Lovell Government Services has been a trusted Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor since 2013 with a proven track record of helping suppliers succeed in the federal marketplace. As a five-time Inc. 5000 honoree, Lovell partners with medical, dental, pharmaceutical, and healthcare technology companies to expand access to federal healthcare systems while helping agencies streamline procurement and improve patient care for Veterans, military personnel, and other federal beneficiaries.
Learn more at www.lovellgov.com.

 

PENSACOLA, Fla. – July 09, 2026 – Lovell® Government Services (Lovell), a Service-Disabled Veteran-Owned Small Business (SDVOSB) and leading federal distribution partner for medical, dental, pharmaceutical, and healthcare technology manufacturers, today announced plans to construct a new state-of-the-art third-party logistics (3PL) distribution center in Northwest Florida. Scheduled for completion in the third quarter of 2027, the facility represents a significant investment in Lovell’s long-term growth strategy and will substantially expand the company’s warehousing, pharmaceutical distribution, fulfillment, and logistics capabilities.

The announcement follows a record-breaking year for Lovell. In 2025, the company had its strongest year to date while earning recognition on the Inc. 5000 list of America’s fastest-growing private companies for the fourth time. During the year, Lovell also expanded its Defense Logistics Agency (DLA) Electronic Catalog (ECAT) footprint, achieved National Association of Boards of Pharmacy (NABP) accreditation for pharmaceutical distribution, and continued expanding access to innovative healthcare technologies across the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), and other federal healthcare systems.

As demand for outsourced logistics and federal distribution services continues to grow, Lovell has expanded well beyond traditional federal contracting. Today, the company provides manufacturers with a fully integrated third-party logistics platform that includes inventory management, secure warehousing, pharmaceutical distribution, order fulfillment, pick-and-pack services, kitting, domestic and international shipping, reverse logistics, customer service, bill-only purchase order processing, sales tracing, inventory reporting, lot tracking, and returns management. These capabilities are seamlessly integrated with Lovell’s federal contracting expertise, allowing manufacturers to streamline operations while expanding access to the federal healthcare market.

Unlike traditional third-party logistics providers, Lovell combines end-to-end fulfillment with comprehensive federal market expertise. In addition to warehousing and distribution, the company provides SDVOSB contract leverage, federal contract management across FSS, GSA, ECAT, and DAPA, federal customer service, bid support, marketing, and sales enablement. By bringing these services together under one roof, manufacturers can consolidate logistics, compliance, customer support, and government contracting with a single trusted partner—reducing operational complexity while accelerating growth within one of the nation’s largest healthcare markets.

The new distribution center will serve as the foundation for Lovell’s next phase of growth. Designed to support the company’s rapidly expanding network of manufacturing partners, the secure, climate-controlled facility will increase warehouse capacity, enhance inventory management and pharmaceutical distribution operations, and improve order fulfillment while providing the scalability needed to support continued expansion. The facility will feature 24-hour surveillance, comprehensive insurance coverage, and around-the-clock service capabilities to ensure the safe and efficient distribution of medical products nationwide.

“Over the past several years, we’ve experienced tremendous growth, not only as a federal contracting partner but also as a trusted logistics provider,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “Our partners are looking for more than warehouse space—they’re looking for a strategic partner capable of managing every aspect of the supply chain while helping them successfully navigate the federal marketplace. This investment reflects our long-term commitment to building the infrastructure, technology, and expertise needed to support our partners for years to come.”

“As more manufacturers look for experienced partners to manage their logistics and federal business, we’re making the investments necessary to meet that demand,” said James Piskorz, General Manager of Lovell 3PL. “This new facility will allow us to expand our capabilities, improve operational efficiencies, and continue delivering the exceptional service our partners and government customers have come to expect.”

The expansion reflects Lovell’s long-term vision of becoming the premier commercialization and logistics partner for manufacturers serving the federal healthcare market. By combining industry-leading logistics capabilities with proven federal contracting expertise, Lovell continues to simplify government market access while helping innovative manufacturers bring critical healthcare technologies to Veterans, active-duty military personnel, and other federal healthcare beneficiaries.

Construction is expected to begin following final planning and permitting, with the new distribution center scheduled to become fully operational in the third quarter of 2027.

About Lovell Government Services

Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a four-time Inc. 5000 honoree and leader in the federal space. The company partners with medical, pharmaceutical, and healthcare technology organizations looking to better serve Veteran and military patient populations, increase their federal revenue stream, and win government contracts.

Learn more at www.lovellgov.com

Media Contact

Jeff McKay
Lovell Government Services
media@lovellgov.com
850-912-4680

 

 

PENSACOLA, FL, UNITED STATES, June 30, 2026 – goGigly, Inc. and Lovell® Government Services today announced a partnership to expand access to Gigly’s AI-powered workforce optimization platform across federal healthcare systems, including the Veterans Health Administration (VHA), the Military Health System (MHS), and the Indian Health Service (IHS).
As part of this collaboration, Lovell Government Services will serve as goGigly’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, supporting access to Gigly’s workforce optimization platform through established federal contracting channels.
Gigly is an AI-powered workforce optimization platform designed specifically for healthcare organizations. Rather than providing contract labor, Gigly helps health systems fill open shifts using the employees they already have. The platform reduces reliance on agency staffing, traveler labor, and overtime by intelligently connecting open shifts with qualified employees already on payroll.
Built specifically for healthcare environments, Gigly provides real-time workforce visibility, intelligent shift distribution, mobile-first employee engagement, and data-driven incentive management. By unlocking existing workforce capacity, Gigly helps healthcare organizations improve shift coverage, reduce labor costs, increase workforce flexibility, and strengthen operational performance.
Through Lovell, Gigly is positioning its platform for streamlined access across federal procurement pathways, helping simplify the acquisition process while supporting agencies in meeting SDVOSB procurement goals. Gigly’s workforce optimization solutions are available through federal contracting vehicles, including the Department of Veterans Affairs Federal Supply Schedule (FSS), GSA Advantage, the Defense Logistics Agency’s Electronic Catalog (ECAT), and the Department of Defense’s Distribution and Pricing Agreement (DAPA), providing government customers with efficient purchasing options.
“Federal healthcare organizations continue to face workforce shortages, rising labor costs, and increasing pressure to do more with existing resources,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “Gigly offers a unique approach by helping organizations maximize the workforce they already employ, reducing dependence on costly external staffing solutions while improving operational flexibility. We are proud to partner with Gigly to help federal healthcare providers strengthen workforce management and improve operational outcomes.”
“Healthcare systems do not always need more workers—they need better visibility into the workforce they already have,” said Julie Schreen, Co-Founder and CEO of goGigly. “Our partnership with Lovell will help bring Gigly’s workforce optimization platform to federal healthcare organizations seeking to improve internal shift coverage, reduce labor costs, and strengthen workforce engagement without relying on additional contract labor. We look forward to supporting VA, DoD, and IHS facilities as they work to optimize staffing resources and enhance patient care delivery.”
About goGigly
goGigly is an AI-powered workforce optimization platform designed specifically for healthcare organizations. The platform helps hospitals, health systems, and healthcare facilities improve shift coverage by connecting open shifts with qualified internal employees through intelligent distribution, real-time notifications, and data-driven incentive management. By maximizing utilization of existing staff, Gigly helps organizations reduce reliance on agency labor, traveler staffing, and overtime while improving workforce flexibility and operational performance.
Learn more at www.gogigly.com
About Lovell Government Services
Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a four-time Inc. 5000 honoree and leader in the federal space. The company partners with medical, pharmaceutical, and healthcare technology organizations looking to better serve Veteran and military patient populations, increase their federal revenue stream, and win government contracts.
Learn more at www.lovellgov.com
Media Contact
Jeff McKay
Lovell Government Services
media@lovellgov.com
850-912-4680
PENSACOLA, FL, UNITED STATES, June 22, 2026 /EINPresswire.com/ — PENSACOLA, FL, UNITED STATES, June, 23, 2026 — Lavior® and Lovell® Government Services today announced a partnership to expand access to Lavior’s advanced botanical wound and skin care products across federal healthcare systems, including the Veterans Health Administration (VHA), the Military Health System (MHS), and the Indian Health Service (IHS).

As part of this collaboration, Lovell Government Services will serve as Lavior’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, supporting access to Lavior products through established federal contracting channels.

Lavior offers a comprehensive line of botanical wound and skin care products formulated specifically for diabetic and post-procedure skin, including its Diabetic Wound Therapy Gel, Advanced Diabetic Wound Hydrogel, Multipurpose Wound Gel, Post-Surgical Skin Barrier Gel, and Diabetic Skin Barrier Cream. Backed by 16 years of research and powered by the bioactive properties of the Inula viscosa AGS-RIED botanical species, Lavior’s U.S.-made formulations help maintain the moist, protective environment essential to wound healing while supporting the skin’s natural barrier. Several products carry HCPCS reimbursement codes (A6248 and A6250) as wound dressings and skin protectants/sealants, making it easier for VA and DoD providers to deliver clinically backed diabetic wound and skin care solutions to the Veteran and military patient populations they serve.

Through Lovell, Lavior is positioning its product portfolio for streamlined access across federal procurement pathways, helping simplify the acquisition process while supporting agencies in meeting SDVOSB procurement goals. Lavior products are available through federal contracting vehicles, including the Department of Veterans Affairs Federal Supply Schedule (FSS), GSA Advantage, the Defense Logistics Agency’s Electronic Catalog (ECAT), and the Department of Defense’s Distribution and Pricing Agreement (DAPA), providing government customers with efficient purchasing options.

“Lovell is proud to partner with Lavior to help bring innovative wound and skin care solutions to federal healthcare providers serving Veterans, active-duty military personnel, and other federal beneficiaries,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “Lavior’s commitment to evidence-based, clinically backed wound care aligns with our mission of connecting government healthcare providers with solutions that can improve patient outcomes and quality of care. We look forward to supporting broader access to these products throughout the federal healthcare system.”
“Getting proven, effective wound and skin care solutions to Veterans and active-duty patients should not be slowed by a complex acquisition process. Through Lovell’s SDVOSB expertise, we are helping federal providers access Lavior’s innovative, botanical, clinically backed formulations more efficiently across the VA, DoD, and IHS,” said Gilad Savion, CEO of Lavior Pharma Inc. “We’re proud to support these agencies in delivering better outcomes for the patients they serve.”

About Lavior
Lavior Pharma Inc. is a botanical pharmaceutical company exclusively dedicated to advanced wound and skin care for diabetic, post-surgical, and everyday use. Drawing on more than 16 years of research into the bioactive properties of the Inula viscosa AGS-RIED botanical species, Lavior develops U.S.-made, clinically backed formulations that support the body’s natural healing process while improving the resilience and appearance of compromised skin. Trusted by clinicians and patients nationwide, Lavior’s products have been featured across national media outlets including ABC, NBC, CBS, and Fox News.
Learn more at www.lavior.com

About Lovell Government Services
Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a four-time Inc. 5000 honoree and leader in the federal space. The company partners with medical and pharmaceutical organizations looking to better serve Veteran and military patient populations, increase their federal revenue stream, and win government contracts.
Learn more at www.lovellgov.com

PENSACOLA, FL, UNITED STATES, June 18, 2026 – Lovell® Government Services and CONMED Corporation, a global medical technology company specializing in surgical devices and equipment, announced today their continued partnership to support federal healthcare facilities pursuing the Association of periOperative Registered Nurses (AORN) Center of Excellence in Surgical Safety: Smoke Evacuation Recognition Program.
The award program recognizes healthcare facilities that have successfully implemented evidence-based surgical smoke evacuation practices to help protect patients and healthcare workers from the hazards associated with surgical smoke exposure. The recognition is available to facilities throughout the Veterans Health Administration (VHA), Military Health System (MHS), and other federal healthcare organizations.
As CONMED’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, Lovell Government Services provides federal healthcare customers access to CONMED’s Buffalo Filter® smoke management solutions through established federal contracting channels. These solutions help facilities meet smoke evacuation requirements while supporting broader surgical safety initiatives.
This year, CONMED is introducing the PlumeSafe® X5, its most advanced smoke evacuation system to date. Designed to support modern operating room environments, the system offers enhanced filtration performance, workflow efficiency, and user-focused features to help healthcare organizations strengthen compliance with smoke evacuation best practices.
In addition to smoke evacuation technology, CONMED supports facilities pursuing AORN recognition through professional clinical education, needs assessments, gap analyses, policy development, and implementation support designed to help healthcare organizations establish sustainable smoke evacuation programs.
To further support adoption across federal healthcare systems, special fourth-quarter pricing is available on select Buffalo Filter smoke evacuation products.
“Protecting healthcare workers and patients from the risks associated with surgical smoke continues to be an important priority across federal healthcare facilities,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “Through our partnership with CONMED, we are helping VA and Department of Defense facilities access proven smoke evacuation technologies and implementation resources that support both compliance objectives and surgical safety initiatives.”
“For 35 years, we have been on a mission to help healthcare teams globally create smoke-free Operating Rooms—because healthcare workers deserve safe, protected environments,” said Sarah Phillips, Sr. Marketing Manager of CONMED. “We are committed to advancing surgical safety, accelerating smoke evacuation adoption, and supporting healthcare providers—including federal partners—in delivering safer care environments.”
CONMED products are available to federal healthcare customers through multiple government procurement channels. Working with Lovell as its SDVOSB vendor helps streamline acquisition while supporting agencies’ socioeconomic procurement goals.

About CONMED

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, and thoracic surgery. For more information, visit www.conmed.com.

About Lovell Government Services

Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a four-time Inc. 5000 honoree and leader in the federal healthcare space. The company partners with medical device, pharmaceutical, and healthcare technology companies looking to better serve Veteran and military patient populations, increase federal revenue opportunities, and win government contracts.
Learn more at www.lovellgov.com

Media Contact

Jeff McKay
Lovell Government Services
949-922-8523
jeff.m@lovellgov.com
The agreement with Lovell Government Services creates opportunities to sell the LIBERTY® System at more than 2,000 government facilities, including those administered by the U.S. Department of Veterans Affairs, the Department of Defense, and the Indian Health Service

HINGHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal healthcare systems, such as those administered by the Veterans Health Administration (VHA), a division of the U.S. Department of Veteran Affairs, the Military Health System (MHS), which is run by the U.S. Department of Defense, and the U.S. Indian Health Service (IHS). Lovell Government Services will become Company’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor to serve these customers through federal contracting systems.

Lovell Government Services has been a SDVOSB vendor since 2013 with a track record of introducing suppliers to the government market. Lovell is a four-time Inc. 5000 honoree. Microbot Medical’s LIBERTY System will be added to Lovell’s Federal Supply Schedule (FSS) contract, with activation expected during the third quarter of 2026. The LIBERTY System will also be accessible through additional federal procurement platforms, including GSA Advantage, the Defense Logistics Agency’s Electronic Catalog (ECAT), and the Department of Defense’s Distribution and Pricing Agreement (DAPA). Listing products with Lovell is expected to streamline the sales process while helping government agencies meet their SDVOSB procurement goals. Lovell serves thousands of government care sites nationwide, including 170 medical centers and numerous outpatient clinics, averaging over 200 peripheral endovascular cases annually, per site.

“We are proud to partner with Microbot Medical to help expand access to innovative healthcare technologies for our nation’s veterans, active-duty service members, and Native American communities,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. “The LIBERTY® Endovascular Robotic System represents a significant advancement in minimally invasive vascular care, and we look forward to supporting its availability across federal healthcare systems. Our mission is to connect government providers with best-in-class solutions that improve patient outcomes while simplifying the procurement process, and this partnership reflects that commitment.”

“As someone who has represented the U.S. in two Olympics, it is an honor to join with Lovell to ensure those who have served in the military along with their physicians have access to advanced medical technologies that address their needs,” commented Christina Bailey, Vice President, U.S. Sales. “Building on our continued commercial momentum, we believe this partnership will expand awareness and adoption of our technology across Lovell’s extensive network. Contracted access is a key component of our commercial strategy, providing customers with a streamlined procurement pathway and confidence in product availability. As interest in our technology continues to grow, we believe now is the right time to start this relationship and its potential for broader adoption.”

About Microbot Medical

Microbot Medical Inc. (NASDAQ: MBOT) is a commercial stage medical device company focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY® Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and safety. Backed by a strong intellectual property portfolio and a commitment to innovation, Microbot is driving the future of endovascular care.

Learn more at www.microbotmedical.com and connect on LinkedIn and X.

Safe Harbor

Statements to future financial and/or operating results, future adoption of products, future growth in research, technology, clinical development, commercialization and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as “contemplates,” “continues,” “could,” “forecasts,” “intends,” “may,” “might,” “possible,” “potential,” “predicts,” “projects,” “should,” “would,” “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates” and similar expressions) should also be considered to be forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions, risks inherent in the commercialization of the LIBERTY® Endovascular Robotic System, and in the development of future versions of or applications for the system, uncertainty in the results of regulatory pathways and regulatory approvals, uncertainty resulting from political, social and geopolitical conditions, particularly any changes in personnel or processes or procedures at the FDA and announcements of tariffs on imports into the U.S., disruptions resulting from new and ongoing hostilities between Israel and the Palestinians, Iran and other neighboring countries, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical® can be found under the heading “Risk Factors” in Microbot Medical’s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC’s web site at www.sec.gov. Microbot Medical® disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Contacts:
IR@microbotmedical.com
Media@microbotmedical.com